188 related articles for article (PubMed ID: 27267877)
21. Malaria rapid testing by community health workers is effective and safe for targeting malaria treatment: randomised cross-over trial in Tanzania.
Mubi M; Janson A; Warsame M; Mårtensson A; Källander K; Petzold MG; Ngasala B; Maganga G; Gustafsson LL; Massele A; Tomson G; Premji Z; Björkman A
PLoS One; 2011; 6(7):e19753. PubMed ID: 21750697
[TBL] [Abstract][Full Text] [Related]
22. Using supply side evidence to inform oral artemisinin monotherapy replacement in Myanmar: a case study.
Khin HS; Aung T; Aung M; Thi A; Boxshall M; ; White C
Malar J; 2016 Aug; 15(1):418. PubMed ID: 27538783
[TBL] [Abstract][Full Text] [Related]
23. Why do health workers give anti-malarials to patients with negative rapid test results? A qualitative study at rural health facilities in western Uganda.
Altaras R; Nuwa A; Agaba B; Streat E; Tibenderana JK; Strachan CE
Malar J; 2016 Jan; 15():23. PubMed ID: 26754484
[TBL] [Abstract][Full Text] [Related]
24. Health workers' compliance to rapid diagnostic tests (RDTs) to guide malaria treatment: a systematic review and meta-analysis.
Kabaghe AN; Visser BJ; Spijker R; Phiri KS; Grobusch MP; van Vugt M
Malar J; 2016 Mar; 15():163. PubMed ID: 26979286
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of a capacity building intervention on malaria treatment for under-fives in rural health facilities in Niger State, Nigeria.
Jegede A; Willey B; Hamade P; Oshiname F; Chandramohan D; Ajayi I; Falade C; Baba E; Webster J
Malar J; 2020 Feb; 19(1):90. PubMed ID: 32093679
[TBL] [Abstract][Full Text] [Related]
26. Molecular Evidence of Drug Resistance in Asymptomatic Malaria Infections, Myanmar, 2015.
Nyunt MH; Shein T; Zaw NN; Han SS; Muh F; Lee SK; Han JH; Thant KZ; Han ET; Kyaw MP
Emerg Infect Dis; 2017 Mar; 23(3):517-520. PubMed ID: 28221121
[TBL] [Abstract][Full Text] [Related]
27. Field evaluation of the 22 rapid diagnostic tests for community management of malaria with artemisinin combination therapy in Cameroon.
Ali IM; Bigoga JD; Forsah DA; Cho-Ngwa F; Tchinda V; Moor VA; Fogako J; Nyongalema P; Nkoa T; Same-Ekobo A; Mbede J; Fondjo E; Mbacham WF; Leke RG
Malar J; 2016 Jan; 15():31. PubMed ID: 26791422
[TBL] [Abstract][Full Text] [Related]
28. Expanding access to parasite-based malaria diagnosis through retail drug shops in Tanzania: evidence from a randomized trial and implications for treatment.
Maloney K; Ward A; Krenz B; Petty N; Bryson L; Dolkart C; Visser T; Le Menach A; Scott VK; Cohen JM; Mtumbuka E; Mkude S
Malar J; 2017 Jan; 16(1):6. PubMed ID: 28049481
[TBL] [Abstract][Full Text] [Related]
29. Challenges in early phase of implementing the 1-3-7 surveillance and response approach in malaria elimination setting: A field study from Myanmar.
Aung PP; Thein ZW; Hein ZNM; Aung KT; Mon NO; Linn NYY; Thi A; Wai KT; Maung TM
Infect Dis Poverty; 2020 Feb; 9(1):18. PubMed ID: 32036792
[TBL] [Abstract][Full Text] [Related]
30. Willingness-to-pay for a rapid malaria diagnostic test and artemisinin-based combination therapy from private drug shops in Mukono District, Uganda.
Hansen KS; Pedrazzoli D; Mbonye A; Clarke S; Cundill B; Magnussen P; Yeung S
Health Policy Plan; 2013 Mar; 28(2):185-96. PubMed ID: 22589226
[TBL] [Abstract][Full Text] [Related]
31. The role of monitoring and evaluation to ensure functional access to community-based early diagnosis and treatment in a malaria elimination programme in Eastern Myanmar.
Rae JD; Nosten S; Proux S; Myint Thu A; Cho WC; Paw K; Paw ES; Shee PB; Be SA; Dah SH; Moo SKL; Minh SMC; Shee PW; Wiladphaingern J; Tun SW; Kajeechiwa L; Thwin MM; Delmas G; Nosten FH; Landier J
Malar J; 2019 Feb; 18(1):50. PubMed ID: 30795764
[TBL] [Abstract][Full Text] [Related]
32. Insights into the availability and distribution of oral artemisinin monotherapy in Myanmar: evidence from a nationally representative outlet survey.
; Thein ST; Khin HSS; Thi A
Malar J; 2017 Apr; 16(1):170. PubMed ID: 28438145
[TBL] [Abstract][Full Text] [Related]
33. [Combined antimalarial therapy using artemisinin].
Majori G
Parassitologia; 2004 Jun; 46(1-2):85-7. PubMed ID: 15305693
[TBL] [Abstract][Full Text] [Related]
34. How long do rapid diagnostic tests remain positive after anti-malarial treatment?
Dalrymple U; Arambepola R; Gething PW; Cameron E
Malar J; 2018 Jun; 17(1):228. PubMed ID: 29884184
[TBL] [Abstract][Full Text] [Related]
35. A cross-sectional study of the availability and price of anti-malarial medicines and malaria rapid diagnostic tests in private sector retail drug outlets in rural Western Kenya, 2013.
Kioko U; Riley C; Dellicour S; Were V; Ouma P; Gutman J; Kariuki S; Omar A; Desai M; Buff AM
Malar J; 2016 Jul; 15(1):359. PubMed ID: 27406179
[TBL] [Abstract][Full Text] [Related]
36. How can malaria rapid diagnostic tests achieve their potential? A qualitative study of a trial at health facilities in Ghana.
Chandler CI; Whitty CJ; Ansah EK
Malar J; 2010 Apr; 9():95. PubMed ID: 20398262
[TBL] [Abstract][Full Text] [Related]
37. Knowledge and malaria treatment practices using artemisinin combination therapy (ACT) in Malawi: survey of health professionals.
Kalilani-Phiri LV; Lungu D; Coghlan R
Malar J; 2011 Sep; 10():279. PubMed ID: 21939507
[TBL] [Abstract][Full Text] [Related]
38. Anti-malarial landscape in Myanmar: results from a nationally representative survey among community health workers and the private sector outlets in 2015/2016.
; Thein ST; Khin HSS; Thi A
Malar J; 2017 Apr; 16(1):129. PubMed ID: 28438197
[TBL] [Abstract][Full Text] [Related]
39. Adoption of rapid diagnostic tests for the diagnosis of malaria, a preliminary analysis of the Global Fund program data, 2005 to 2010.
Zhao J; Lama M; Korenromp E; Aylward P; Shargie E; Filler S; Komatsu R; Atun R
PLoS One; 2012; 7(8):e43549. PubMed ID: 22952703
[TBL] [Abstract][Full Text] [Related]
40. [Practices of caregivers and national recommendations for treatment of malaria in Benin in 2009].
Robin S; Bruneton C; Guévart E
Bull Soc Pathol Exot; 2017 Aug; 110(3):207-216. PubMed ID: 28144847
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
